PrEP, PEP & nPEP

PrEP (Pre-Exposure Prophylaxis)  A comprehensive HIV prevention strategy that involves the daily use of antiretroviral medications to reduce the risk of HIV infection in HIV-negative individuals.

PEP (Post-Exposure Prophylaxis) Taking antiretroviral medicines (ART) after being potentially exposed to HIV to prevent becoming infected.

nPEP (Non-occupational Post-Exposure Prophylaxis) Short-term treatment started as soon as possible after high-risk non-occupational exposure to an infectious agent, such as HIV, hepatitis B virus (HBV), or hepatitis C virus (HCV).

News

• PrEP During COVID-19 (HIV.gov) The Centers for Disease Control and Prevention (CDC) understands that its partners in HIV prevention are facing unprecedented challenges and demands as we continue to battle the COVID-19 pandemic together. CDC has developed guidance for providing PrEP when facility-based services and in-person patient-clinician contact is limited.
• HHS Seeks Vendor(s) to Distribute PrEP Medications as Part of Ready, Set, PrEP * (HIV.gov) The U.S. Department of Health & Human Services (HHS) requires a vendor(s) to distribute pre-exposure prophylaxis (PrEP) medications as part of a donation agreement between HHS and Gilead to provide PrEP medication at no cost for up to 200,000 individuals a year who are at risk for HIV and who are uninsured.
• Ready, Set, PrEP Expands Access to Medication to Prevent HIV *  HRSA News December 3 – The U.S. Department of Health and Human Services (HHS) today launched Ready, Set, PrEP, a national program that makes medications for pre-exposure prophylaxis (PrEP), taken daily to prevent HIV, available at no cost to people without prescription drug insurance coverage.

Training

• Online Course on PrEP Counseling for Transgender and Gender Non-Binary Clients * Available for continuing education credit until June 11, 2020.
• Training on PrEP and Young Black MSM (Technical Assistance) * CME/CNE Term of Approval: September 2020 – ANAC; September 2020 – IDSA/HIVMA

Resources

• FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic *
• AIDSinfo HIV Prevention Consumer Fact Sheets: Post-Exposure Prophylaxis (PEP) *
• AIDSinfo HIV Prevention Consumer Fact Sheets: Pre-Exposure Prophylaxis (PrEP) *
• AIDSVu Adds 2017 State-Level Data Visualizing PrEP Users Across the U.S. *
• Sexual Assault: PEP is an Urgent Health Need *
• PrEPcost.org is Now Available for 2019 Individual Health Plans *
• NASTAD’s PrEPcost.org Training Video *
• New CDC Initiative Educates Providers about PrEP and PEP *
• CDC Discussions on Pre-Exposure Prophylaxis and Women: Summary *
• The Miami-Dade County PrEP/PEP Provider brochure
• PrEP Locator – www.preplocator.org *
• Medication Assistance Program and Co-Pay Programs for PrEP *
• HIV/STD and PrEP Website from the Free UHealth Clinic at Walgreens *
• PrEP Study at University of Miami Miller School of Medicine (Ft. Lauderdale)

PrEP & PEP Providers in Miami-Dade County

• Florida Department of Health PrEP Clinic *
• Borinquen Medical Center Specialty Care Center *
• Care Resource Community Health Center *
• Empower U Community Health Center *
• Miami Beach Community Health Center Stanley Myers Center *
• Project Access Foundation *
• University of Miami/JMH Adolescent Medicine Clinic *
• University of Miami Urgent Care *

This page includes links to Ryan White Program and non-Ryan White Program funded services. Please contact your Medical Case Manager with questions about Ryan White Program eligibility.

By clicking links marked by an asterisk (*), you acknowledge you are leaving AIDSNET.org. We are not responsible for the content on these web sites.